These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30699147)

  • 21. Population pharmacokinetics of epinastine, a histamine H1 receptor antagonist, in adults and children.
    Sarashina A; Tatami S; Yamamura N; Tsuda Y; Igarashi T
    Br J Clin Pharmacol; 2005 Jan; 59(1):43-53. PubMed ID: 15606439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adsorption of levocabastine eye drops by soft contact lenses and its effects in rabbit eyes.
    Momose T; Ito N; Kanai A; Watanabe Y; Shibata M
    CLAO J; 1997 Apr; 23(2):96-9. PubMed ID: 9108973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
    Brodsky M; Berger WE; Butrus S; Epstein AB; Irkec M
    Eye Contact Lens; 2003 Apr; 29(2):113-6. PubMed ID: 12695716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental studies on soft contact lenses for controlled ocular delivery of pirfinedone: in vitro and in vivo.
    Yang M; Yang Y; Lei M; Ye C; Zhao C; Xu J; Wu K; Yu M
    Drug Deliv; 2016 Nov; 23(9):3538-3543. PubMed ID: 27331555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epinastine ophthalmic solution (Elestat).
    Med Lett Drugs Ther; 2004 Apr; 46(1181):35-6. PubMed ID: 15114254
    [No Abstract]   [Full Text] [Related]  

  • 26. Simultaneous measurement of epinastine and its metabolite, 9,13b-dehydroepinastine, in human plasma by a newly developed ultra-performance liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies.
    Jeong SH; Jang JH; Cho HY; Lee YB
    Biomed Chromatogr; 2020 Sep; 34(9):e4848. PubMed ID: 32302007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
    Leroy T; van Neste D
    Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A laboratory model to determine the uptake and release of olopatadine by soft contact lenses.
    Dassanayake NL; Carey TC; Owen GR
    Acta Ophthalmol Scand Suppl; 2000; (230):16-7. PubMed ID: 11057343
    [No Abstract]   [Full Text] [Related]  

  • 29. Allergic conjunctivitis and contact lenses: experience with olopatadine hydrochloride 0.1% therapy.
    Brodsky M
    Acta Ophthalmol Scand Suppl; 2000; (230):56-9. PubMed ID: 11057353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological and clinical profile of epinastine hydrochloride (Alesion Dry Syrup 1%)].
    Ohmura T; Kawasaki T
    Nihon Yakurigaku Zasshi; 2006 Jan; 127(1):37-46. PubMed ID: 16508222
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.
    Figus M; Fogagnolo P; Lazzeri S; Capizzi F; Romagnoli M; Canovetti A; Iester M; Ferreras A; Rossetti L; Nardi M
    Eur J Ophthalmol; 2010; 20(5):811-8. PubMed ID: 20383847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of epinastine, a histamine H1 receptor antagonist, in human liver microsomes in comparison with that of terfenadine.
    Kishimoto W; Hiroi T; Sakai K; Funae Y; Igarashi T
    Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):273-92. PubMed ID: 9485522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous drug delivery through the use of disposable contact lenses.
    Lesher GA; Gunderson GG
    Optom Vis Sci; 1993 Dec; 70(12):1012-8. PubMed ID: 8115123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers.
    Schilling JC; Adamus WS; Kuthan H
    Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):493-7. PubMed ID: 1982280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended Ciprofloxacin Release Using Vitamin E Diffusion Barrier From Commercial Silicone-Based Soft Contact Lenses.
    Shayani Rad M; Mohajeri SA
    Eye Contact Lens; 2017 Mar; 43(2):103-109. PubMed ID: 26863046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Special indications for the use of soft contact lenses as a drug-release-system (author's transl)].
    Bietti GB; De Caro G; Giraldi JP; Romani E
    Klin Monbl Augenheilkd; 1976 Jan; 168(1):33-43. PubMed ID: 979031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tailored gatifloxacin Pluronic® F-68-loaded contact lens: Addressing the issue of transmittance and swelling.
    Maulvi FA; Parmar RJ; Desai AR; Desai DM; Shukla MR; Ranch KM; Shah SA; Shah DO
    Int J Pharm; 2020 May; 581():119279. PubMed ID: 32240806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye.
    Lekhanont K; Park CY; Combs JC; Suwan-Apichon O; Rangsin R; Chuck RS
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):83-8. PubMed ID: 17341156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic Comparison of Epinastine Using Developed Human Plasma Assays.
    Jeong SH; Jang JH; Cho HY; Lee YB
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31947890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition.
    Kamei C; Akagi M; Mio M; Kitazumi K; Izushi K; Masaki S; Tasaka K
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):191-205. PubMed ID: 1375955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.